Guidance Up, Trend Intact: Veeva Is Today’s Double-Confirmation Stock
For questions about this article or underlying research, email help@trefis.com.
Veeva Systems (VEEV) raised its fiscal 2027 earnings forecast on August 26, 2026, and the stock has gained 30.7% since the close prior to that release. Over the same period, the S&P 500 slipped 0.18%. Management’s own projections align with the share price trajectory. So what exactly did Veeva raise, what does its chart show, and what could push the stock higher?
Veeva Systems’ Guidance Raise
In its August 26 release, management raised its fiscal 2027 forecast for adjusted earnings per share to $9.21 from the $9.05 projection given in June. That marks a 1.8% increase to management’s own estimate for the same year. Executives also lifted the revenue forecast by a smaller margin, targeting a range of $3.68 billion to $3.69 billion, up from $3.64 billion.
Management paired the higher forecast with a second quarter that it said came in ahead of its own guidance, posting revenue of $928 million. Veeva announced both figures in the same release, meaning investors reacted to the quarterly results and the new forecast together.
What We See In The Chart For Veeva
Veeva closed at $322.55 on October 22, trading 17.1% above its 50-day average, which measures the average closing price over the last 50 trading days. This 50-day metric currently sits above the 200-day average, or the average close over the last 200 trading days. The current share price stands 56.0% above that longer-term measure. The trend remains intact across both averages, and the October 22 close marked the highest level of the past year.
The stock’s gain since the release occurred in two distinct, similarly sized phases. Over the two sessions from August 25 to August 27, Veeva rose 14.3% while the S&P 500 gained 0.7%. The stock has added another 14.3% since then, continuing its climb well after the initial news, while the broader index dipped 0.87%.
Is There Room Left To Run For Veeva Stock?
Veeva expects fiscal third-quarter revenue of $932 million to $935 million. At the midpoint, this projection represents about 15% growth from the $811 million reported in the same quarter a year earlier. Second-quarter revenue grew 17.6%, so management’s third-quarter forecast implies slower growth than Veeva posted in the prior period.
Faster growth would have to come from the customers Veeva is still winning for its software. The company said on September 15 that Amgen plans to roll out Vault CRM worldwide, and announced on October 13 that IQVIA had selected its clinical operations applications, including CTMS and eTMF. Management also said it would hold an Investor Day on November 5. The stock already trades at 51.6 times Veeva’s reported earnings over the last twelve months, compared with 23.0 for the S&P 500.
For now, Veeva’s raised forecast and its chart point in the same direction. The company’s underlying business is what would keep the two aligned: quarters that exceed management’s own guidance, and quicker growth from customer wins such as Amgen and IQVIA. A quarter that falls short, or a share price that slips below its averages, would pull them apart. Veeva’s next earnings report, expected in November, will reveal where third-quarter revenue landed against the guided range.
Is Too Much Of Your Wealth Riding On One Stock?
Veeva Systems holders are relying on a forecast that management still has to deliver. When one position grows into a large part of your wealth, a sharp fall can hurt your whole plan, and selling to spread the money out can bring a large tax bill. Our partner advisory firm offers a free strategy review of ways to protect a concentrated position and unwind it with less tax.
Request A Free Strategy Review
Spot an error or want more like this? Tell us in 10 seconds.